Bisphosphonates and avascular necrosis of the jaw: a possible association.
Carter
Glen
G
Oral and Maxillofacial Surgery Unit, Royal Adelaide Hospital and Adelaide Dental Hospital, SA, Australia.
Goss
Alastair N
AN
Doecke
Chris
C
D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D008134:Long-Term Care; D008297:Male; D008336:Mandibular Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008439:Maxillary Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008875:Middle Aged; D009101:Multiple Myeloma / Q000000981:diagnostic imaging / Q000188:drug therapy; D010001:Osteitis Deformans / Q000000981:diagnostic imaging / Q000188:drug therapy; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D000077268:Pamidronate; D012307:Risk Factors; D014057:Tomography, X-Ray Computed
D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D000077268:Pamidronate; D019386:Alendronate